Spatial control of membrane receptor function using ligand nanocalipers

Nature Methods

Volumn 11, Issue 8, 2014, Pages 841-846

  Shaw, Alan ^a   Lundin, Vanessa ^a   Petrova, Ekaterina ^a   Fördos, Ferenc ^a   Benson, Erik ^a   Al Amin, Abdullah ^a   Herland, Anna ^a   Blokzijl, Andries ^b   Högberg, Björn ^a   Teixeira, Ana I ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN; EPHRIN A5; EPHRIN RECEPTOR A2; LIGAND; MEMBRANE RECEPTOR;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; DNA STRUCTURE; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR INVASION;

ENDOCYTOSIS; LIGANDS; NANOTECHNOLOGY; RECEPTORS, CELL SURFACE;

EID: 84905283658     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nMeth.3025     Document Type: Article

References (37)

1. Casaletto, J.B. & McClatchey, A.I. Spatial regulation of receptor tyrosine kinases in development and cancer. Nat. Rev. Cancer 12, 387-400 (2012).
2. Salaita, K. et al. Restriction of receptor movement alters cellular response: physical force sensing by EphA2. Science 327, 1380-1385 (2010).
3. Lohmüller, T. et al. Supported membranes embedded with fxed arrays of gold nanoparticles. Nano Lett. 11, 4912-4918 (2011).
4. Holmberg, J. et al. Ephrin-A2 reverse signaling negatively regulates neural progenitor proliferation and neurogenesis. Genes Dev. 19, 462-471 (2005).
5. Pasquale, E.B. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat. Rev. Cancer 10, 165-180 (2010).
6. Miao, H. et al. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt. Cancer Cell 16, 9-20 (2009).
7. Batlle, E. et al. EphB receptor activity suppresses colorectal cancer progression. Nature 435, 1126-1130 (2005).
8. Genander, M. et al. Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression. Cell 139, 679-692 (2009).
9. Bethani, I., Skånland, S.S., Dikic, I. & Acker-Palmer, A. Spatial organization of transmembrane receptor signalling. EMBO J. 29, 2677-2688 (2010).
10. Davis, S. et al. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 266, 816-819 (1994).
11. Wykosky, J. et al. Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor. Oncogene 27, 7260-7273 (2008).
12. Stein, E. et al. Eph receptors discriminate specifc ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev. 12, 667-678 (1998).
13. Egea, J. et al. Regulation of EphA 4 kinase activity is required for a subset of axon guidance decisions suggesting a key role for receptor clustering in Eph function. Neuron 47, 515-528 (2005).
14. Seeman, N.C. Nanomaterials based on DNA. Annu. Rev. Biochem. 79, 65-87 (2010).
15. Rothemund, P.W.K. Folding DNA to create nanoscale shapes and patterns. Nature 440, 297-302 (2006).
16. Högberg, B. & Olin, H. DNA-scaffolded nanoparticle structures. J. Phys. Conf. Ser. 61, 458-462 (2007).
17. Voigt, N.V. et al. Single-molecule chemical reactions on DNA origami. Nat. Nanotechnol. 5, 200-203 (2010).
18. Selmi, D.N. et al. DNA-templated protein arrays for single-molecule imaging. Nano Lett. 11, 657-660 (2011).
19. Rinker, S., Ke, Y., Liu, Y., Chhabra, R. & Yan, H. Self-assembled DNA nanostructures for distance-dependent multivalent ligand-protein binding. Nat. Nanotechnol. 3, 418-422 (2008).
20. Park, S.H. et al. Programmable DNA self-assemblies for nanoscale organization of ligands and proteins. Nano Lett. 5, 729-733 (2005).
21. Derr, N.D. et al. Tug-of-war in motor protein ensembles revealed with a programmable DNA origami scaffold. Science 338, 662-665 (2012).
22. Douglas, S.M., Bachelet, I. & Church, G.M. A logic-gated nanorobot for targeted transport of molecular payloads. Science 335, 831-834 (2012).
23. Douglas, S.M. et al. Self-assembly of DNA into nanoscale three-dimensional shapes. Nature 459, 414-418 (2009).
24. Andersen, E.S. et al. Self-assembly of a nanoscale DNA box with a controllable lid. Nature 459, 73-76 (2009).
25. Abulrob, A. et al. Nanoscale imaging of epidermal growth factor receptor clustering: effects of inhibitors. J. Biol. Chem. 285, 3145-3156 (2010).
26. Lajoie, P. et al. Plasma membrane domain organization regulates EGFR signaling in tumor cells. J. Cell Biol. 179, 341-356 (2007).
27. Castro, C.E. et al. A primer to scaffolded DNA origami. Nat. Methods 8, 221-229 (2011).
28. Söderberg, O. et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 3, 995-1000 (2006).
29. Pitulescu, M.E. & Adams, R.H. Eph/ephrin molecules-a hub for signaling and endocytosis. Genes Dev. 24, 2480-2492 (2010).
30. Zhuang, G., Hunter, S., Hwang, Y. & Chen, J. Regulation of EphA2 receptor endocytosis by SHIP2 lipid phosphatase via phosphatidylinositol 3-Kinase-dependent Rac1 activation. J. Biol. Chem. 282, 2683-2694 (2007).
31. Hiramoto-Yamaki, N. et al. Ephexin4 and EphA2 mediate cell migration through a RhoG-dependent mechanism. J. Cell Biol. 190, 461-477 (2010).
32. Macrae, M. et al. A conditional feedback loop regulates Ras activity through EphA2. Cancer Cell 8, 111-118 (2005).
33. Himanen, J.P. et al. Architecture of Eph receptor clusters. Proc. Natl. Acad. Sci. USA 107, 10860-10865 (2010).
34. Seiradake, E., Harlos, K., Sutton, G., Aricescu, A.R. & Jones, E.Y. An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly. Nat. Struct. Mol. Biol. 17, 398-402 (2010).
35. Wimmer-Kleikamp, S.H., Janes, P.W., Squire, A., Bastiaens, P.I.H. & Lackmann, M. Recruitment of Eph receptors into signaling clusters does not require ephrin contact. J. Cell Biol. 164, 661-666 (2004).
36. Mitov, M.I., Greaser, M.L. & Campbell, K.S. GelBandFitter-a computer program for analysis of closely spaced electrophoretic and immunoblotted bands. Electrophoresis 30, 848-851 (2009).
37. Coffman, K.T. et al. Differential EphA2 epitope display on normal versus malignant cells. Cancer Res. 63, 7907-7912 (2003).